Logo image of NBY

NOVABAY PHARMACEUTICALS INC (NBY) Stock Analyst Ratings

USA - NYSEARCA:NBY - US66987P4090 - Common Stock

1.3 USD
+0.26 (+25%)
Last: 10/20/2025, 5:05:00 PM
1.27 USD
-0.03 (-2.31%)
After Hours: 10/20/2025, 5:05:00 PM
Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to NBY. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 0.87. This target is -33.31% below the current price.
NBY was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about NBY.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed NBY. So this is just the average opinion of a couple of analysts.

Related screens

NBY Historical Analyst RatingsNBY Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -105 -95 -85 -75 -65 -55 -45 -35 -25 -15 -5 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 1.300.860.870.870.89 - -33.96% -33.31% -33.31% -31.35%

Related screens

NBY Current Analyst RatingNBY Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2024-11-11 Ascendiant Capital Maintains Buy -> Buy
2023-08-11 Ladenburg Thalmann Maintains Buy -> Buy
2022-05-20 Ascendiant Capital Maintains Buy